Loading...
OTC Markets
Totals
Securities
12,214
Dollar Vol
$2.7B
Share Vol
3.1B
Trades
358,241

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

TXTM
ProText Mobility, Inc.

Common Stock

0.0049

0.0003

6.52%

0.0049 / 0.005 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 07/18/2025
Delayed (15 Min) Trade Data: 12:00am 07/18/2025

0.0046

0.0043 - 0.005

26,140,329

N/A

Real-Time Level 2 Quote
Bid
Ask
MPID
MPID
Bid Price
Bid Price
Size
Size
Time
Time
ETRF
24.90>year
CDEL
21.9203/16
MACM
18.95>year
NITE
18.95>year
CSTI
18.55>year
MPID
MPID
Ask Price
Ask Price
Size
Size
Time
Time
INTL
19.40>year
NITE
19.40>year
MACM
19.43>year
MAXM
20.11>year
CANT
22.05>year
Unlock Real-Time quotes For TXTMFind Out More
Trade Data
News
Filings and Disclosure
Company Description
ProText Mobility, Inc. Company Logo
Protext is a Biotech Company developing a Hemp/CBD -- Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Through its wholly owned subsidiary RSAMMD Acquisitions LLC ("RSAMMDA") and under the leadership of its founders Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabis. Mr. Du Plooy is a South African pioneer in the research and cultivation. Dr. J operates a 5000-hectare farm in New Castle, South Africa and holds hemp permit issued by the Government of South Africa, Department of Agriculture. Together the RSAMMDA founders have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. The company is committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world.
Videos
OTCID Market Logo
OTCID
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.